Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medartis Holding AGXSWX:MED -1.24%87 Equity-to-Asset is 0.49 as of Dec. 2025, which is 33% below its 10-year median of 0.73. GuruFocus rates XSWX:MED with a GF Score™ of 87/100 and a GF Value™ of CHF108.21 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Medartis Holding AG ranks worse than 68.58% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Medartis Holding AG's Total Stockholders Equity for the quarter that ended in Dec. 2025 was CHF275.9 Mil. Medartis Holding AG's Total Assets for the quarter that ended in Dec. 2025 was CHF559.9 Mil.
Therefore, Medartis Holding AG's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.49.
The historical rank and industry rank for Medartis Holding AG's Equity-to-Asset or its related term are showing as below:
XSWX:MED'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.13 Med: 0.73 Max: 0.85
Current: 0.49
During the past 12 years, the highest Equity to Asset Ratio of Medartis Holding AG was 0.85. The lowest was 0.13. And the median was 0.73.
XSWX:MED's Equity-to-Asset is ranked worse than 68.58% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs XSWX:MED: 0.49
Medartis Holding AG (XSWX:MED) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Medartis Holding AG Equity-to-Asset Related Terms
Medartis Holding AG Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MED vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, Medartis Holding AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Medartis Holding AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (XSWX:MED) has a Equity-to-Asset of 0.49 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Medartis Holding AG and its competitors. This is 33% below median its historical median of 0.73. Over the past decade, Medartis Holding AG's Equity-to-Asset has ranged from 0.13 to 0.85. According to the industry distribution chart, Medartis Holding AG ranks #585 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 68.6%.
Is Medartis Holding AG's Equity-to-Asset too high?
Medartis Holding AG's current Equity-to-Asset of 0.49 is 33% below median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 0.85. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Medartis Holding AG's value of 0.49 is 23.4% below this industry median. Based on the distribution chart, Medartis Holding AG ranks #585 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medartis Holding AG has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #585 out of 853 companies for Equity-to-Asset. This places Medartis Holding AG in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Medartis Holding AG's value of 0.49 is 23.4% below this benchmark. Historically, Medartis Holding AG's own Equity-to-Asset has ranged from 0.13 to 0.85 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 0.64, Medartis Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current Equity-to-Asset of 0.49 is 23.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current Equity-to-Asset is 0.49, which is 33% below median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF108.21, compared to a current price of CHF87.80 — trading 18.9% below its estimated fair value. The current Equity-to-Asset is 0.49, which is 33% below median its 10-year median of 0.73 and 23.4% below the Medical Devices & Instruments industry median of 0.64. Medartis Holding AG's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Equity-to-Asset is 0.49 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF87.80 is trading 18.9% below its estimated GF Value™ of CHF108.21.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
Equity-to-Asset: 0.49 (33% below median its 10-year median of 0.73)
GF Value™: CHF108.21 vs. price of CHF87.80 (18.9% below fair value)
Industry Position: 23.4% below the Medical Devices & Instruments median (#585 of 853)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
87GF Score
Get the complete analysis for XSWX:MED
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
